Abstract
Perioperative blood loss during elective total joint arthroplasty (TJA) can be significant, traditionally resulting in high blood transfusion rates. However, due to the risks and costs of allogeneic blood transfusion, the focus in contemporary TJA has been on strategies to minimize perioperative blood loss. While a multimodal approach is paramount in elective TJA, three main factors have contributed dramatically to the reduced allogeneic blood transfusion rates: (1) preoperative assessment and treatment of anemia, (2) expanded use of antifibrinolytics, particularly tranexamic acid (TXA), and (3) a restrictive transfusion strategy postoperatively.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 259-263 |
| Number of pages | 5 |
| Journal | Seminars in Arthroplasty |
| Volume | 28 |
| Issue number | 4 |
| DOIs | |
| State | Published - Dec 1 2017 |
Fingerprint
Keywords
- Blood conservation
- Total hip arthroplasty (THA)
- Total joint arthroplasty (TJA)
- Total knee arthroplasty (TKA)
- Tranexamic acid (TXA)
ASJC Scopus subject areas
- Surgery
- Orthopedics and Sports Medicine
Cite this
Blood conservation : Preoperative, perioperative, and postoperative blood management options. / Chalmers, Brian P.; Abdel, Matthew.
In: Seminars in Arthroplasty, Vol. 28, No. 4, 01.12.2017, p. 259-263.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Blood conservation
T2 - Preoperative, perioperative, and postoperative blood management options
AU - Chalmers, Brian P.
AU - Abdel, Matthew
PY - 2017/12/1
Y1 - 2017/12/1
N2 - Perioperative blood loss during elective total joint arthroplasty (TJA) can be significant, traditionally resulting in high blood transfusion rates. However, due to the risks and costs of allogeneic blood transfusion, the focus in contemporary TJA has been on strategies to minimize perioperative blood loss. While a multimodal approach is paramount in elective TJA, three main factors have contributed dramatically to the reduced allogeneic blood transfusion rates: (1) preoperative assessment and treatment of anemia, (2) expanded use of antifibrinolytics, particularly tranexamic acid (TXA), and (3) a restrictive transfusion strategy postoperatively.
AB - Perioperative blood loss during elective total joint arthroplasty (TJA) can be significant, traditionally resulting in high blood transfusion rates. However, due to the risks and costs of allogeneic blood transfusion, the focus in contemporary TJA has been on strategies to minimize perioperative blood loss. While a multimodal approach is paramount in elective TJA, three main factors have contributed dramatically to the reduced allogeneic blood transfusion rates: (1) preoperative assessment and treatment of anemia, (2) expanded use of antifibrinolytics, particularly tranexamic acid (TXA), and (3) a restrictive transfusion strategy postoperatively.
KW - Blood conservation
KW - Total hip arthroplasty (THA)
KW - Total joint arthroplasty (TJA)
KW - Total knee arthroplasty (TKA)
KW - Tranexamic acid (TXA)
UR - http://www.scopus.com/inward/record.url?scp=85043244335&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85043244335&partnerID=8YFLogxK
U2 - 10.1053/j.sart.2018.02.008
DO - 10.1053/j.sart.2018.02.008
M3 - Article
AN - SCOPUS:85043244335
VL - 28
SP - 259
EP - 263
JO - Seminars in Arthroplasty
JF - Seminars in Arthroplasty
SN - 1045-4527
IS - 4
ER -